Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA expands approval of Sutent to reduce the risk of kidney cancer returning

November 16, 2017Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

FDA approves first adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed.

Post navigation

← FDA approves new treatment to prevent bleeding in certain patients with hemophilia A Lipari Foods, LLC. Issues Voluntary Product Recall of Specific Dark Chocolate Products Due to Undeclared Milk Allergen →
Proudly powered by WordPress